Narcolepsy and rapid eye movement sleep.
cataplexy
history
hypersomnia
orexin/hypocretin
sleep‐onset rapid eye movement period
Journal
Journal of sleep research
ISSN: 1365-2869
Titre abrégé: J Sleep Res
Pays: England
ID NLM: 9214441
Informations de publication
Date de publication:
02 Jul 2024
02 Jul 2024
Historique:
revised:
06
06
2024
received:
07
05
2024
accepted:
09
06
2024
medline:
3
7
2024
pubmed:
3
7
2024
entrez:
2
7
2024
Statut:
aheadofprint
Résumé
Since the first description of narcolepsy at the end of the 19th Century, great progress has been made. The disease is nowadays distinguished as narcolepsy type 1 and type 2. In the 1960s, the discovery of rapid eye movement sleep at sleep onset led to improved understanding of core sleep-related disease symptoms of the disease (excessive daytime sleepiness with early occurrence of rapid eye movement sleep, sleep-related hallucinations, sleep paralysis, rapid eye movement parasomnia), as possible dysregulation of rapid eye movement sleep, and cataplexy resembling an intrusion of rapid eye movement atonia during wake. The relevance of non-sleep-related symptoms, such as obesity, precocious puberty, psychiatric and cardiovascular morbidities, has subsequently been recognized. The diagnostic tools have been improved, but sleep-onset rapid eye movement periods on polysomnography and Multiple Sleep Latency Test remain key criteria. The pathogenic mechanisms of narcolepsy type 1 have been partly elucidated after the discovery of strong HLA class II association and orexin/hypocretin deficiency, a neurotransmitter that is involved in altered rapid eye movement sleep regulation. Conversely, the causes of narcolepsy type 2, where cataplexy and orexin deficiency are absent, remain unknown. Symptomatic medications to treat patients with narcolepsy have been developed, and management has been codified with guidelines, until the recent promising orexin-receptor agonists. The present review retraces the steps of the research on narcolepsy that linked the features of the disease with rapid eye movement sleep abnormality, and those that do not appear associated with rapid eye movement sleep.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14277Informations de copyright
© 2024 The Author(s). Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Sleep Research Society.
Références
American Academy of Sleep Medicine. (2005). The international classification of sleep disorders: Diagnostic & Coding Manual. 297 https://search.worldcat.org/title/67281425
American Academy of Sleep Medicine (Ed.). (2014). International classification of sleep disorders (3rd ed.). American Academy of Sleep Medicine. https://doi.org/10.1007/978-1-4939-6578-6_27
American Academy of Sleep Medicine. (2023). International classification of sleep disorders, third edition, text revision (ICSD‐3‐TR). https://aasm.org/clinical-resources/international-classification-sleep-disorders/
Andlauer, O., Moore, H., Hong, S.‐C., Dauvilliers, Y., Kanbayashi, T., Nishino, S., Han, F., Silber, M. H., Rico, T., Einen, M., Kornum, B. R., Jennum, P., Knudsen, S., Nevsimalova, S., Poli, F., Plazzi, G., & Mignot, E. (2012). Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep, 35(9), 1247–1255. https://doi.org/10.5665/sleep.2080
Andlauer, O., Moore, H., Jouhier, L., Drake, C., Peppard, P. E., Han, F., Hong, S. C., Poli, F., Plazzi, G., O'Hara, R., Haffen, E., Roth, T., Young, T., & Mignot, E. (2013). Nocturnal rapid eyemovement sleep latency for identifying patients with narcolepsy/hypocretin deficiency. JAMA Neurology, 70(7), 891–902. https://doi.org/10.1001/jamaneurol.2013.1589
Antelmi, E., Ferri, R., Iranzo, A., Arnulf, I., Dauvilliers, Y., Bhatia, K. P., Liguori, R., Schenck, C. H., & Plazzi, G. (2016). From state dissociation to status dissociatus. Sleep Medicine Reviews, 28, 5–17. https://doi.org/10.1016/j.smrv.2015.07.003
Antelmi, E., Filardi, M., Pizza, F., Vandi, S., Moresco, M., Franceschini, C., Tinazzi, M., Ferri, R., & Plazzi, G. (2021). REM sleep behavior disorder in children with type 1 narcolepsy treated with sodium Oxybate. Neurology, 96(2), e250–e254. https://doi.org/10.1212/WNL.0000000000011157
Antelmi, E., Pizza, F., Donadio, V., Filardi, M., Sosero, Y. L., Incensi, A., Vandi, S., Moresco, M., Ferri, R., Marelli, S., Ferini‐Strambi, L., Liguori, R., & Plazzi, G. (2019). Biomarkers for REM sleep behavior disorder in idiopathic and narcoleptic patients. Annals of Clinical and Translational Neurology, 6(9), 1872–1876. https://doi.org/10.1002/ACN3.50833
Antelmi, E., Pizza, F., Vandi, S., Neccia, G., Ferri, R., Bruni, O., Filardi, M., Cantalupo, G., Liguori, R., & Plazzi, G. (2017). The spectrum of REM sleep‐related episodes in children with type 1 narcolepsy. Brain, 140(6), 1669–1679. https://doi.org/10.1093/brain/awx096
Aran, A., Einen, M., Lin, L., Plazzi, G., Nishino, S., & Mignot, E. (2010). Clinical and therapeutic aspects of childhood narcolepsy‐cataplexy: A retrospective study of 51 children. Sleep, 33(11), 1457–1464. https://doi.org/10.1093/SLEEP/33.11.1457
Aserinsky, E., & Kleitman, N. (1953). Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science, 118(3062), 273–274. https://doi.org/10.1126/science.118.3062.273
Barateau, L., Chenini, S., Denis, C., Lorber, Q., Béziat, S., Jaussent, I., & Dauvilliers, Y. (2024). Narcolepsy severity scale‐2 and idiopathic hypersomnia severity scale to better quantify symptoms severity and consequences in narcolepsy type 2. Sleep, 47, zsad323. https://doi.org/10.1093/SLEEP/ZSAD323
Barateau, L., Chenini, S., Lotierzo, M., Rassu, A. L., Evangelista, E., Lopez, R., Gorce Dupuy, A. M., Jaussent, I., & Dauvilliers, Y. (2020). CSF and serum ferritin levels in narcolepsy type 1 comorbid with restless legs syndrome. Annals of Clinical and Translational Neurology, 7(6), 924–931. https://doi.org/10.1002/ACN3.51056
Barateau, L., & Dauvilliers, Y. (2019). Recent advances in treatment for narcolepsy. Therapeutic Advances in Neurological Disorders, 12, 175628641987562. https://doi.org/10.1177/1756286419875622
Barateau, L., & Dauvilliers, Y. (2023). Cardiovascular burden of narcolepsy: What have we learned and what do we still need to know? Sleep, 46(10), zsad213. https://doi.org/10.1093/SLEEP/ZSAD213
Barateau, L., Jaussent, I., Lopez, R., Evangelista, E., Chenini, S., Benkiran, M., Mariano‐Goulart, D., & Dauvilliers, Y. (2018). Cardiac sympathetic activity differentiates idiopathic and symptomatic rapid eye movement sleep behaviour disorder. Scientific Reports, 8(1), 7304. https://doi.org/10.1038/S41598-018-25547-W
Barateau, L., Lopez, R., Chenini, S., Pesenti, C., Rassu, A. L., Jaussent, I., & Dauvilliers, Y. (2020). Depression and suicidal thoughts in untreated and treated narcolepsy: Systematic analysis. Neurology, 95(20), E2755–E2768. https://doi.org/10.1212/WNL.0000000000010737
Barateau, L., Lopez, R., Chenini, S., Rassu, A. L., Mouhli, L., Dhalluin, C., Jaussent, I., & Dauvilliers, Y. (2022). Linking clinical complaints and objective measures of disrupted nighttime sleep in narcolepsy type 1. Sleep, 45(6), zsac054. https://doi.org/10.1093/SLEEP/ZSAC054
Barateau, L., Lopez, R., Chenini, S., Rassu, A. L., Scholz, S., Lotierzo, M., Cristol, J. P., Jaussent, I., & Dauvilliers, Y. (2020). Association of CSF orexin‐A levels and nocturnal sleep stability in patients with hypersomnolence. Neurology, 95(21), E2900–E2911. https://doi.org/10.1212/WNL.0000000000010743
Barateau, L., Pizza, F., Chenini, S., Peter‐Derex, L., & Dauvilliers, Y. (2023). Narcolepsies, update in 2023. Revue Neurologique, 179(7), 727–740. https://doi.org/10.1016/j.neurol.2023.08.001
Bassetti, C. L. A., Adamantidis, A., Burdakov, D., Han, F., Gay, S., Kallweit, U., Khatami, R., Koning, F., Kornum, B. R., Lammers, G. J., Liblau, R. S., Luppi, P. H., Mayer, G., Pollmächer, T., Sakurai, T., Sallusto, F., Scammell, T. E., Tafti, M., & Dauvilliers, Y. (2019). Narcolepsy — Clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nature Reviews Neurology, 15(9), 519–539. https://doi.org/10.1038/s41582-019-0226-9
Bassetti, C. L. A., Kallweit, U., Vignatelli, L., Plazzi, G., Lecendreux, M., Baldin, E., Dolenc‐Groselj, L., Jennum, P., Khatami, R., Manconi, M., Mayer, G., Partinen, M., Pollmächer, T., Reading, P., Santamaria, J., Sonka, K., Dauvilliers, Y., & Lammers, G. J. (2021). European guideline and expert statements on the management of narcolepsy in adults and children. European Journal of Neurology, 28(9), 2815–2830. https://doi.org/10.1111/ene.14888
Bastianini, S., Silvani, A., Berteotti, C., Lo Martire, V., & Zoccoli, G. (2012). High‐amplitude theta wave bursts during REM sleep and cataplexy in hypocretin‐deficient narcoleptic mice. Journal of Sleep Research, 21(2), 185–188. https://doi.org/10.1111/J.1365-2869.2011.00945.X
Baumann, C. R., Mignot, E., Lammers, G. J., Overeem, S., Arnulf, I., Rye, D., Dauvilliers, Y., Honda, M., Owens, J. A., Plazzi, G., & Scammell, T. E. (2014). Challenges in diagnosing narcolepsy without cataplexy: A consensus statement. Sleep, 37(6), 1035–1042. https://doi.org/10.5665/SLEEP.3756
Ben‐Joseph, R. H., Saad, R., Black, J., Dabrowski, E. C., Taylor, B., Gallucci, S., & Somers, V. K. (2023). Cardiovascular burden of narcolepsy disease (CV‐BOND): A real‐world evidence study. Sleep, 46(10), zsad161. https://doi.org/10.1093/SLEEP/ZSAD161
Billiard, M., Seignalet, J., Besset, A., & Cadilhac, J. (1986). HLA‐DR2 and narcolepsy. Sleep, 9(1 Pt 2), 149–152. https://doi.org/10.1093/SLEEP/9.1.149
Bin‐Hasan, S., Videnovic, A., & Maski, K. (2018). Nocturnal REM sleep without atonia is a diagnostic biomarker of pediatric narcolepsy. Journal of Clinical Sleep Medicine, 14(2), 245–252. https://doi.org/10.5664/jcsm.6944
Black, J., Reaven, N. L., Funk, S. E., McGaughey, K., Ohayon, M. M., Guilleminault, C., & Ruoff, C. (2017). Medical comorbidity in narcolepsy: Findings from the Burden of Narcolepsy Disease (BOND) study. Sleep Medicine, 33, 13–18. https://doi.org/10.1016/j.sleep.2016.04.004
Blouin, A. M., Fried, I., Wilson, C. L., Staba, R. J., Behnke, E. J., Lam, H. A., Maidment, N. T., Karlsson, K., Lapierre, J. L., & Siegel, J. M. (2013). Human hypocretin and melanin‐concentrating hormone levels are linked to emotion and social interaction. Nature Communications, 4, 1547. https://doi.org/10.1038/NCOMMS2461
Bogan, R. K., Thorpy, M. J., Dauvilliers, Y., Partinen, M., Del Rio Villegas, R., Foldvary‐Schaefer, N., Skowronski, R., Tang, L., Skobieranda, F., & Šonka, K. (2021). Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower‐sodium oxybate [LXB]; JZP‐258) in a placebo‐controlled, double‐blind, randomized withdrawal study in adults with narcolepsy with cataplexy. Sleep, 44(3), 1–13. https://doi.org/10.1093/SLEEP/ZSAA206
Bosco, A., Lopez, R., Barateau, L., Chenini, S., Pesenti, C., Pépin, J. L., Jaussent, I., & Dauvilliers, Y. (2018). Effect of psychostimulants on blood pressure profile and endothelial function in narcolepsy. Neurology, 90(6), e479–e491. https://doi.org/10.1212/WNL.0000000000004911
Boscolo‐Berto, R., Viel, G., Montagnese, S., Raduazzo, D. I., Ferrara, S. D., & Dauvilliers, Y. (2012). Narcolepsy and effectiveness of gamma‐hydroxybutyrate (GHB): A systematic review and meta‐analysis of randomized controlled trials. Sleep Medicine Reviews, 16(5), 431–443. https://doi.org/10.1016/j.smrv.2011.09.001
Bozluolcay, M., Nalbantoglu, M., Benbir Senel, G., & Karadeniz, D. (2015). What does one sleep‐onset REM period—During either nocturnal polysomnography or multiple sleep latency test—Mean in differential diagnosis of central Hypersomnias? Journal of Clinical Neurophysiology, 32(4), 364–368. https://doi.org/10.1097/WNP.0000000000000192
Broughton, R., & Mamelak, M. (1979). The treatment of narcolepsy‐cataplexy with nocturnal gamma‐hydroxybutyrate. Canadian Journal of Neurological Sciences/Journal Canadien des Sciences Neurologiques, 6(1), 1–6. https://doi.org/10.1017/S0317167100119304
Burgess, C. R., Oishi, Y., Mochizuki, T., Peever, J. H., & Scammell, T. E. (2013). Amygdala lesions reduce cataplexy in orexin knock‐out mice. The Journal of Neuroscience, 33(23), 9734–9742. https://doi.org/10.1523/JNEUROSCI.5632-12.2013
Busková, J., Kemlink, D., Ibarburu, V., Nevsímalová, S., & Sonka, K. (2015). Antidepressants substantially affect basic REM sleep characteristics in narcolepsy‐cataplexy patients. Neuro Endocrinology Letters, 36(5), 430–433.
Cesari, M., Egger, K., Stefani, A., Bergmann, M., Ibrahim, A., Brandauer, E., Högl, B., & Heidbreder, A. (2023). Differentiation of central disorders of hypersomnolence with manual and artificial‐intelligence‐derived polysomnographic measures. Sleep, 46(2), zsac288. https://doi.org/10.1093/SLEEP/ZSAC288
Christensen, J. A. E., Carrillo, O., Leary, E. B., Peppard, P. E., Young, T., Sorensen, H. B. D., Jennum, P., & Mignot, E. (2015). Sleep‐stage transitions during polysomnographic recordings as diagnostic features of type 1 narcolepsy. Sleep Medicine, 16(12), 1558–1566. https://doi.org/10.1016/j.sleep.2015.06.007
Christensen, J. A. E., Kempfner, L., Leonthin, H. L., Hvidtfelt, M., Nikolic, M., Kornum, B. R., & Jennum, P. (2017). Novel method for evaluation of eye movements in patients with narcolepsy. Sleep Medicine, 33, 171–180. https://doi.org/10.1016/j.sleep.2016.10.016
Cipolli, C., Franceschini, C., Mattarozzi, K., Mazzetti, M., & Plazzi, G. (2011). Overnight distribution and motor characteristics of REM sleep behaviour disorder episodes in patients with narcolepsy‐cataplexy. Sleep Medicine, 12(7), 635–640. https://doi.org/10.1016/J.SLEEP.2010.12.016
Cipolli, C., Pizza, F., Bellucci, C., Mazzetti, M., Tuozzi, G., Vandi, S., & Plazzi, G. (2020). Structural organization of dream experience during daytime sleep‐onset rapid eye movement period sleep of patients with narcolepsy type 1. Sleep, 43(8), zsaa012. https://doi.org/10.1093/SLEEP/ZSAA012
Dahmen, N., Kasten, M., Mittag, K., & Müller, M. J. (2002). Narcoleptic and schizophrenic hallucinations. Implications for differential diagnosis and pathophysiology. The European Journal of Health Economics, 3(s), S94‐8. https://doi.org/10.1007/S10198-002-0113-X
D'anselmo, A., Agnoli, S., Filardi, M., Pizza, F., Mastria, S., Corazza, G. E., & Plazzi, G. (2020). Creativity in narcolepsy type 1: The role of dissociated REM sleep manifestations. Nature and Science of Sleep, 12, 1191–1200. https://doi.org/10.2147/NSS.S277647
Dauvilliers, Y., Barateau, L., Lopez, R., Rassu, A. L., Chenini, S., Beziat, S., & Jaussent, I. (2020). Narcolepsy severity scale: A reliable tool assessing symptom severity and consequences. Sleep, 43(6), 1–11. https://doi.org/10.1093/SLEEP/ZSAA009
Dauvilliers, Y., Bassetti, C., Lammers, G. J., Arnulf, I., Mayer, G., Rodenbeck, A., Lehert, P., Ding, C. L., Lecomte, J. M., & Schwartz, J. C. (2013). Pitolisant versus placebo or modafinil in patients with narcolepsy: A double‐blind, randomised trial. The Lancet Neurology, 12(11), 1068–1075. https://doi.org/10.1016/S1474-4422(13)70225-4
Dauvilliers, Y., Bauer, J., Rigau, V., Lalloyer, N., Labauge, P., Carlander, B., Liblau, R., Peyron, C., & Lassmann, H. (2013). Hypothalamic immunopathology in anti‐Ma‐associated diencephalitis with narcolepsy‐cataplexy. JAMA Neurology, 70(10), 1305–1310. https://doi.org/10.1001/JAMANEUROL.2013.2831
Dauvilliers, Y., Baumann, C. R., Carlander, B., Bischof, M., Blatter, T., Lecendreux, M., Maly, F., Besset, A., Touchon, J., Billiard, M., Tafti, M., & Bassetti, C. L. (2003). CSF hypocretin‐1 levels in narcolepsy, Kleine‐Levin syndrome, and other hypersomnias and neurological conditions. Journal of Neurology, Neurosurgery and Psychiatry, 74(12), 1667–1673. https://doi.org/10.1136/jnnp.74.12.1667
Dauvilliers, Y., Billiard, M., & Montplaisir, J. (2003). Clinical aspects and pathophysiology of narcolepsy. Clinical Neurophysiology, 114(11), 2000–2017. https://doi.org/10.1016/S1388-2457(03)00203-7
Dauvilliers, Y., Bogan, R. K., Šonka, K., Partinen, M., Foldvary‐Schaefer, N., & Thorpy, M. J. (2022). Calcium, magnesium, potassium, and sodium oxybates oral solution: A lower‐sodium alternative for cataplexy or excessive daytime sleepiness associated with narcolepsy. In Nature and science of sleep (Vol. 14, pp. 531–546). Dove Medical Press Ltd. https://doi.org/10.2147/NSS.S279345
Dauvilliers, Y., Gosselin, A., Paquet, J., Touchon, J., Billiard, M., & Montplaisir, J. (2004). Effect of age on MSLT results in patients with narcolepsy‐cataplexy. Neurology, 62(1), 46–50. https://doi.org/10.1212/01.wnl.0000101725.34089.1e
Dauvilliers, Y., Jaussent, I., Krams, B., Scholz, S., Lado, S., Levy, P., & Pepin, J. L. (2012). Non‐dipping blood pressure profile in narcolepsy with cataplexy. PLoS One, 7(6), e38977. https://doi.org/10.1371/journal.pone.0038977
Dauvilliers, Y., Mignot, E., del Río Villegas, R., Du, Y., Hanson, E., Inoue, Y., Kadali, H., Koundourakis, E., Meyer, S., Rogers, R., Scammell, T. E., Sheikh, S. I., Swick, T., Szakács, Z., von Rosenstiel, P., Wu, J., Zeitz, H., Murthy, N. V., Plazzi, G., & von Hehn, C. (2023). Oral orexin receptor 2 agonist in narcolepsy type 1. The New England Journal of Medicine, 389(4), 309–321. https://doi.org/10.1056/NEJMOA2301940
Dauvilliers, Y., Montplaisir, J., Molinari, N., Carlander, B., Ondze, B., Besset, A., & Billiard, M. (2001). Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology, 57(11), 2029–2033. https://doi.org/10.1212/WNL.57.11.2029
Dauvilliers, Y., Paquereau, J., Bastuji, H., Drouot, X., Weil, J. S., & Viot‐Blanc, V. (2009). Psychological health in central hypersomnias: The French Harmony study. Journal of Neurology, Neurosurgery and Psychiatry, 80(6), 636–641. https://doi.org/10.1136/jnnp.2008.161588
Dauvilliers, Y., Pennestri, M. H., Petit, D., Dang‐Vu, T., Lavigne, G., & Montplaisir, J. (2007). Periodic leg movements during sleep and wakefulness in narcolepsy. Journal of Sleep Research, 16(3), 333–339. https://doi.org/10.1111/J.1365-2869.2007.00601.X
Dauvilliers, Y., Rompré, S., Gagnon, J. F., Vendette, M., Petit, D., & Montplaisir, J. (2007). REM sleep characteristics in narcolepsy and REM sleep behavior disorder. Sleep, 30(7), 844–849. https://doi.org/10.1093/SLEEP/30.7.844
Dauvilliers, Y., Roth, T., Bogan, R., Thorpy, M. J., Morse, A. M., Roy, A., Dubow, J., & Gudeman, J. (2023). Efficacy of once‐nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: Post hoc analysis from the phase 3 REST‐ON trial. Sleep, 46(11), zsad152. https://doi.org/10.1093/SLEEP/ZSAD152
Dauvilliers, Y., Schenck, C. H., Postuma, R. B., Iranzo, A., Luppi, P. H., Plazzi, G., Montplaisir, J., & Boeve, B. (2018). REM sleep behaviour disorder. Nature Reviews Disease Primers, 4(1), 19. https://doi.org/10.1038/s41572-018-0016-5
Dauvilliers, Y., Shapiro, C., Mayer, G., Lammers, G. J., Emsellem, H., Plazzi, G., Chen, D., Carter, L. P., Lee, L., Black, J., & Thorpy, M. J. (2020). Solriamfetol for the treatment of excessive daytime sleepiness in participants with narcolepsy with and without cataplexy: Subgroup analysis of efficacy and safety data by cataplexy status in a randomized controlled trial. CNS Drugs, 34(7), 773–784. https://doi.org/10.1007/S40263-020-00744-2
Dauvilliers, Y., Siegel, J. M., Lopez, R., Torontali, Z. A., & Peever, J. H. (2014). Cataplexy–clinical aspects, pathophysiology and management strategy. Nature Reviews. Neurology, 10(7), 386–395. https://doi.org/10.1038/NRNEUROL.2014.97
Dauvilliers, Y., Šonka, K., Bogan, R. K., Partinen, M., Del Rio Villegas, R., Foldvary‐Schaefer, N., Skowronski, R., Chen, A., Black, J., Skobieranda, F., & Thorpy, M. J. (2022). Changes in cataplexy frequency in a clinical trial of lower‐sodium oxybate with taper and discontinuation of other anticataplectic medications. CNS Drugs, 36(6), 633–647. https://doi.org/10.1007/S40263-022-00926-0
Dauvilliers, Y. A., & Laberge, L. (2012). Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation. Sleep Medicine Reviews, 16(6), 539–545. https://doi.org/10.1016/J.SMRV.2012.01.001
DelRosso, L. M., Mogavero, M. P., Fickensher, A., Bruni, O., Schenck, C. H., & Ferri, R. (2023). Effects of bupropion and SSRI antidepressants on leg movement activity and chin muscle tone during sleep in adolescents. Journal of Clinical Sleep Medicine, 19(1), 151–161. https://doi.org/10.5664/JCSM.10282
Dement, W., Rechtschaffen, A., & Gulevich, G. (1966). The nature of the narcoleptic sleep attack. Neurology, 16(1), 18–33. https://doi.org/10.1212/WNL.16.1.18
Diagnostic Classification Steering Committee. (1990). International classification of sleep disorders: Diagnostic and coding manual. American Sleep Disorders Association.
Diniz Behn, C. G., Klerman, E. B., Mochizuki, T., Lin, S. C., & Scammell, T. E. (2010). Abnormal sleep/wake dynamics in orexin knockout mice. Sleep, 33(3), 297–306. https://doi.org/10.1093/SLEEP/33.3.297
Dodet, P., Chavez, M., Leu‐Semenescu, S., Golmard, J. L., & Arnulf, I. (2015). Lucid dreaming in narcolepsy. Sleep, 38(3), 487–497. https://doi.org/10.5665/SLEEP.4516
Drakatos, P., Kosky, C. A., Higgins, S. E., Muza, R. T., Williams, A. J., & Leschziner, G. D. (2013). First rapid eye movement sleep periods and sleep‐onset rapid eye movement periods in sleep‐stage sequencing of hypersomnias. Sleep Medicine, 14(9), 897–901. https://doi.org/10.1016/j.sleep.2013.03.021
Drakatos, P., Suri, A., Higgins, S. E., Ebrahim, I. O., Muza, R. T., Kosky, C. A., Williams, A. J., & Leschziner, G. D. (2013). Sleep stage sequence analysis of sleep onset REM periods in the hypersomnias. Journal of Neurology, Neurosurgery, and Psychiatry, 84(2), 223–227. https://doi.org/10.1136/jnnp-2012-303578
Droogleever Fortuyn, H. A., Mulders, P. C., Renier, W. O., Buitelaar, J. K., & Overeem, S. (2011). Narcolepsy and psychiatry: An evolving association of increasing interest. Sleep Medicine, 12(7), 714–719. https://doi.org/10.1016/J.SLEEP.2011.01.013
Evans, R., Kimura, H., Alexander, R., Davies, C. H., Faessel, H., Hartman, D. S., Ishikawa, T., Ratti, E., Shimizu, K., Suzuki, M., Tanaka, S., Yukitake, H., Dauvilliers, Y., & Mignot, E. (2022). Orexin 2 receptor‐selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients. Proceedings of the National Academy of Sciences of the United States of America, 119(35), e2207531119. https://doi.org/10.1073/PNAS.2207531119
Feng, H., Wen, S. Y., Qiao, Q. C., Pang, Y. J., Wang, S. Y., Li, H. Y., Cai, J., Zhang, K. X., Chen, J., Hu, Z. A., Luo, F. L., Wang, G. Z., Yang, N., & Zhang, J. (2020). Orexin signaling modulates synchronized excitation in the sublaterodorsal tegmental nucleus to stabilize REM sleep. Nature Communications, 11(1), 3661. https://doi.org/10.1038/S41467-020-17401-3
Ferri, R., DelRosso, L. M., Aricò, D., Zucconi, M., Ferini‐Strambi, L., Picchietti, D. L., Pizza, F., Plazzi, G., Manconi, M., & Bruni, O. (2018). Leg movement activity during sleep in school‐age children and adolescents: A detailed study in normal controls and participants with restless legs syndrome and narcolepsy type 1. Sleep, 41(4), zsy010. https://doi.org/10.1093/SLEEP/ZSY010
Ferri, R., Franceschini, C., Zucconi, M., Vandi, S., Poli, F., Bruni, O., Cipolli, C., Montagna, P., & Plazzi, G. (2008). Searching for a marker of REM sleep behavior disorder: Submentalis muscle EMG amplitude analysis during sleep in patients with narcolepsy/cataplexy. Sleep, 31(10), 1409–1417.
Ferri, R., Miano, S., Bruni, O., Vankova, J., Nevsimalova, S., Vandi, S., Montagna, P., Ferini‐Strambi, L., & Plazzi, G. (2005). NREM sleep alterations in narcolepsy/cataplexy. Clinical Neurophysiology, 116(11), 2675–2684. https://doi.org/10.1016/J.CLINPH.2005.08.004
Ferri, R., Mogavero, M. P., Bruni, O., Picchietti, D. L., & DelRosso, L. M. (2023). Periodic leg movements during sleep associated with antidepressants: A meta‐analysis. Neuroscience and Biobehavioral Reviews, 148, 105126. https://doi.org/10.1016/J.NEUBIOREV.2023.105126
Ferri, R., Mogavero, M. P., Bruni, O., Plazzi, G., Schenck, C. H., & Delrosso, L. M. (2021). Increased chin muscle tone during all sleep stages in children taking selective serotonin reuptake inhibitor antidepressants and in children with narcolepsy type 1. Sleep, 44(11), zsab147. https://doi.org/10.1093/SLEEP/ZSAB147
Ferri, R., Pizza, F., Vandi, S., Iloti, M., & Plazzi, G. (2016). Decreased sleep stage transition pattern complexity in narcolepsy type 1. Clinical Neurophysiology, 127(8), 2812–2819. https://doi.org/10.1016/J.CLINPH.2016.05.364
Ferri, R., Zucconi, M., Manconi, M., Bruni, O., Ferini‐Strambi, L., Vandi, S., Montagna, P., Mignot, E., & Plazzi, G. (2006). Different periodicity and time structure of leg movements during sleep in narcolepsy/cataplexy and restless legs syndrome. Sleep, 29(12), 1587–1594. https://doi.org/10.1093/SLEEP/29.12.1587
Fischer, F. (1878). Epileptoide schlafzustände. European Archives of Psychiatry and Clinical Neuroscience https://scholar.archive.org/work/bg2agqje2fdoxhia4m7lfa664y/access/ia_file/crossref‐pre‐1909‐scholarly‐works/10.1007%252Fbf01790217.zip/10.1007%252Fbf01791317.pdf
Fronczek, R., Arnulf, I., Baumann, C. R., Maski, K., Pizza, F., & Trotti, L. M. (2020). To split or to lump? Classifying the central disorders of hypersomnolence. Sleep, 43(8), zsaa044. https://doi.org/10.1093/SLEEP/ZSAA044
Gelineau, J. B. E. (1880). De la narcolepsie. Gazette Des Hôpitaux https://cir.nii.ac.jp/crid/1570009750286366464
Goldbart, A., Peppard, P., Finn, L., Ruoff, C. M., Barnet, J., Young, T., & Mignot, E. (2014). Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort. Sleep, 37(6), 1043–1051. https://doi.org/10.5665/SLEEP.3758
Gool, J. K., Zhang, Z., Oei, M. S. S. L., Mathias, S., Dauvilliers, Y., Mayer, G., Plazzi, G., Del Rio‐Villegas, R., Cano, J. S., Šonka, K., Partinen, M., Overeem, S., Peraita‐Adrados, R., Heinzer, R., Martins Da Silva, A., Högl, B., Wierzbicka, A., Heidbreder, A., Feketeova, E., … Lammers, G. J. (2022). Data‐driven phenotyping of central disorders of hypersomnolence with unsupervised clustering. Neurology, 98(23), E2387–E2400. https://doi.org/10.1212/WNL.0000000000200519
Grimaldi, D., Calandra‐Buonaura, G., Provini, F., Agati, P., Pierangeli, G., Franceschini, C., Barletta, G., Plazzi, G., Montagna, P., & Cortelli, P. (2012). Abnormal sleep‐cardiovascular system interaction in narcolepsy with cataplexy: Effects of hypocretin deficiency in humans. Sleep, 35(4), 519–528. https://doi.org/10.5665/sleep.1738
Guilleminault, C., Carskadon, M., & Dement, W. C. (1974). On the treatment of rapid eye movement narcolepsy. Archives of Neurology, 30(1), 90–93. https://doi.org/10.1001/ARCHNEUR.1974.00490310092014
Guilleminault, C., Phillips, R., & Dement, W. C. (1975). A syndrome of hypersomnia with automatic behavior. Electroencephalography and Clinical Neurophysiology, 38(4), 403–413. https://doi.org/10.1016/0013-4694(75)90264-3
Hanin, C., Arnulf, I., Maranci, J. B., Lecendreux, M., Levinson, D. F., Cohen, D., & Laurent‐Levinson, C. (2021). Narcolepsy and psychosis: A systematic review. Acta Psychiatrica Scandinavica, 144(1), 28–41. https://doi.org/10.1111/acps.13300
Hansen, M. H., Kornum, B. R., & Jennum, P. (2017). Sleep‐wake stability in narcolepsy patients with normal, low and unmeasurable hypocretin levels. Sleep Medicine, 34, 1–6. https://doi.org/10.1016/j.sleep.2017.01.021
Hasegawa, E., Maejima, T., Yoshida, T., Masseck, O. A., Herlitze, S., Yoshioka, M., Sakurai, T., & Mieda, M. (2017). Serotonin neurons in the dorsal raphe mediate the anticataplectic action of orexin neurons by reducing amygdala activity. Proceedings of the National Academy of Sciences of the United States of America, 114(17), E3526–E3535. https://doi.org/10.1073/PNAS.1614552114
Hasegawa, E., Yanagisawa, M., Sakurai, T., & Mieda, M. (2014). Orexin neurons suppress narcolepsy via 2 distinct efferent pathways. The Journal of Clinical Investigation, 124(2), 604–616. https://doi.org/10.1172/JCI71017
Huang, Y.‐S., Guilleminault, C., Lin, C.‐H., Chen, C.‐H., Chin, W.‐C., & Chen, T.‐S. (2018). Multiple sleep latency test in narcolepsy type 1 and narcolepsy type 2: A 5‐year follow‐up study. Journal of Sleep Research, 27(5), e12700. https://doi.org/10.1111/jsr.12700
Inocente, C. O., Gustin, M. P., Lavault, S., Guignard‐Perret, A., Raoux, A., Christol, N., Gerard, D., Dauvilliers, Y., Reimão, R., Bat‐Pitault, F., Lin, J. S., Arnulf, I., Lecendreux, M., & Franco, P. (2014a). Depressive feelings in children with narcolepsy. Sleep Medicine, 15(3), 309–314. https://doi.org/10.1016/J.SLEEP.2013.08.798
Inocente, C. O., Gustin, M. P., Lavault, S., Guignard‐Perret, A., Raoux, A., Christol, N., Gerard, D., Dauvilliers, Y., Reimão, R., Bat‐Pitault, F., Lin, J. S., Arnulf, I., Lecendreux, M., & Franco, P. (2014b). Quality of life in children with narcolepsy. CNS Neuroscience & Therapeutics, 20(8), 763–771. https://doi.org/10.1111/CNS.12291
Irukayama‐Tomobe, Y., Ogawa, Y., Tominaga, H., Ishikawa, Y., Hosokawa, N., Ambai, S., Kawabe, Y., Uchida, S., Nakajima, R., Saitoh, T., Kanda, T., Vogt, K., Sakurai, T., Nagase, H., & Yanagisawa, M. (2017). Nonpeptide orexin type‐2 receptor agonist ameliorates narcolepsy‐cataplexy symptoms in mouse models. Proceedings of the National Academy of Sciences of the United States of America, 114(22), 5731–5736. https://doi.org/10.1073/pnas.1700499114
Ito, H., Fukatsu, N., Rahaman, S. M., Mukai, Y., Izawa, S., Ono, D., Kilduff, T. S., & Yamanaka, A. (2023). Deficiency of orexin signaling during sleep is involved in abnormal REM sleep architecture in narcolepsy. Proceedings of the National Academy of Sciences of the United States of America, 120(41), e2301951120. https://doi.org/10.1073/PNAS.2301951120
Jardri, R., Bartels‐Velthuis, A. A., Debbané, M., Jenner, J. A., Kelleher, I., Dauvilliers, Y., Plazzi, G., Demeulemeester, M., David, C. N., Rapoport, J., Dobbelaere, D., Escher, S., & Fernyhough, C. (2014). From phenomenology to neurophysiological understanding of hallucinations in children and adolescents. Schizophrenia Bulletin, 40(Suppl 4), S221–S232. https://doi.org/10.1093/SCHBUL/SBU029
Jennum, P., Ibsen, R., Knudsen, S., & Kjellberg, J. (2013). Comorbidity and mortality of narcolepsy: A controlled retro‐ and prospective national study. Sleep, 36(6), 835–840. https://doi.org/10.5665/sleep.2706
Jennum, P., Pickering, L., Thorstensen, E. W., Ibsen, R., & Kjellberg, J. (2017). Morbidity of childhood onset narcolepsy: A controlled national study. Sleep Medicine, 29, 13–17. https://doi.org/10.1016/j.sleep.2016.09.013
Jin, L., Shi, L., Zhang, Y., Chen, B. B., Wang, X. L., & Liu, Y. H. (2019). Antidepressants for the treatment of narcolepsy: A prospective study of 148 patients in Northern China. Journal of Clinical Neuroscience, 63, 27–31. https://doi.org/10.1016/J.JOCN.2019.02.014
Juji, T., Satake, M., Honda, Y., & Doi, Y. (1984). HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens, 24(5), 316–319. https://doi.org/10.1111/J.1399-0039.1984.TB02144.X
Kaushik, M. K., Aritake, K., Imanishi, A., Kanbayashi, T., Ichikawa, T., Shimizu, T., Urade, Y., & Yanagisawa, M. (2018). Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy. Proceedings of the National Academy of Sciences of the United States of America, 115(23), 6046–6051. https://doi.org/10.1073/PNAS.1722686115
Kawai, R., Watanabe, A., Fujita, S., Hirose, M., Esaki, Y., Arakawa, C., Iwata, N., & Kitajima, T. (2020). Utility of the sleep stage sequence preceding sleep onset REM periods for the diagnosis of narcolepsy: A study in a Japanese cohort. Sleep Medicine, 68, 9–17. https://doi.org/10.1016/j.sleep.2019.04.008
Knecht, C. D., Oliver, J. E., Redding, R., Selcer, R., & Johnson, G. (1973). Narcolepsy in a dog and a cat. Journal of the American Veterinary Medical Association, 162(12), 1052–1053.
Knudsen, S., Gammeltoft, S., & Jennum, P. J. (2010). Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin‐1 deficiency. Brain: A Journal of Neurology, 133(Pt 2), 568–579. https://doi.org/10.1093/brain/awp320
Kornum, B. R., Knudsen, S., Ollila, H. M., Pizza, F., Jennum, P. J., Dauvilliers, Y., & Overeem, S. (2017). Narcolepsy. Nature Reviews. Disease Primers, 3:16100. https://doi.org/10.1038/NRDP.2016.100
Krahn, L. E., Arand, D. L., Avidan, A. Y., Davila, D. G., DeBassio, W. A., Ruoff, C. M., & Harrod, C. G. (2021). Recommended protocols for the multiple sleep latency test and maintenance of wakefulness test in adults: Guidance from the American Academy of Sleep Medicine. Journal of Clinical Sleep Medicine, 17(12), 2489–2498. https://doi.org/10.5664/jcsm.9620
Lacaux, C., Izabelle, C., Santantonio, G., De Villèle, L., Frain, J., Lubart, T., Pizza, F., Plazzi, G., Arnulf, I., & Oudiette, D. (2019). Increased creative thinking in narcolepsy. Brain, 142(7), 1988–1999. https://doi.org/10.1093/brain/awz137
Lammers, G. J., Arends, J., Declerck, A. C., Ferrari, M. D., Schouwink, G., & Troost, J. (1993). Gammahydroxybutyrate and narcolepsy: A double‐blind placebo‐controlled study. Sleep, 16(3), 216–220. https://doi.org/10.1093/sleep/16.3.216
Lammers, G. J., Bassetti, C. L. A., Dolenc‐Groselj, L., Jennum, P. J., Kallweit, U., Khatami, R., Lecendreux, M., Manconi, M., Mayer, G., Partinen, M., Plazzi, G., Reading, P. J., Santamaria, J., Sonka, K., & Dauvilliers, Y. (2020). Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts. Sleep medicine reviews 52, 101306. https://doi.org/10.1016/j.smrv.2020.101306
Langdon, N., Van Dam, M., Welsh, K. I., Vaughan, R. W., & Parkes, D. (1984). Genetic markers in narcolepsy. Lancet, 2(8413), 1178–1180. https://doi.org/10.1016/S0140-6736(84)92742-9
Latorre, D., Kallweit, U., Armentani, E., Foglierini, M., Mele, F., Cassotta, A., Jovic, S., Jarrossay, D., Mathis, J., Zellini, F., Becher, B., Lanzavecchia, A., Khatami, R., Manconi, M., Tafti, M., Bassetti, C. L., & Sallusto, F. (2018). T cells in patients with narcolepsy target self‐antigens of hypocretin neurons. Nature, 562(7725), 63–68. https://doi.org/10.1038/S41586-018-0540-1
Lecendreux, M., Lavault, S., Lopez, R., Inocente, C. O., Konofal, E., Cortese, S., Franco, P., Arnulf, I., & Dauvilliers, Y. (2015). Attention‐deficit/hyperactivity disorder (ADHD) symptoms in pediatric narcolepsy: A cross‐sectional study. Sleep, 38(8), 1285–1295. https://doi.org/10.5665/SLEEP.4910
Lecendreux, M., Plazzi, G., Dauvilliers, Y., Rosen, C. L., Ruoff, C., Black, J., Parvataneni, R., Guinta, D., Wang, Y. G., & Mignot, E. (2022). Long‐term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients. Journal of Clinical Sleep Medicine, 18(9), 2217–2227. https://doi.org/10.5664/JCSM.10090
Lee, K., Baron, K., Soca, R., & Attarian, H. (2016). The prevalence and characteristics of REM sleep without atonia (RSWA) in patients taking antidepressants. Journal of Clinical Sleep Medicine, 12(3), 351–355. https://doi.org/10.5664/jcsm.5582
Leu‐Semenescu, S., Maranci, J. B., Lopez, R., Drouot, X., Dodet, P., Gales, A., Groos, E., Barateau, L., Franco, P., Lecendreux, M., Dauvilliers, Y., & Arnulf, I. (2022). Comorbid parasomnias in narcolepsy and idiopathic hypersomnia: More REM than NREM parasomnias. Journal of Clinical Sleep Medicine, 18(5), 1355–1364. https://doi.org/10.5664/JCSM.9862
Liblau, R. S., Latorre, D., Kornum, B. R., Dauvilliers, Y., & Mignot, E. J. (2023). The immunopathogenesis of narcolepsy type 1. In Nature reviews immunology. Nature Research. https://doi.org/10.1038/s41577-023-00902-9
Lin, J. S., Dauvilliers, Y., Arnulf, I., Bastuji, H., Anaclet, C., Parmentier, R., Kocher, L., Yanagisawa, M., Lehert, P., Ligneau, X., Perrin, D., Robert, P., Roux, M., Lecomte, J. M., & Schwartz, J. C. (2008). An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: Studies in orexin‐/‐ mice and patients. Neurobiology of Disease, 30(1), 74–83. https://doi.org/10.1016/J.NBD.2007.12.003
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., De Jong, P. J., Nishino, S., & Mignot, E. (1999). The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 98(3), 365–376. https://doi.org/10.1016/S0092-8674(00)81965-0
Littner, M. R., Kushida, C., Wise, M., Davila, D. G., Morgenthaler, T., Lee‐Chiong, T., Hirshkowitz, M., Loube, D. L., Bailey, D., Berry, R. B., Kapen, S., & Kramer, M. (2005). Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep, 28(1), 113–121. https://doi.org/10.1093/SLEEP/28.1.113
Liu, Y., Zhang, J., Lam, V., Ho, C. K. W., Zhou, J., Li, S. X., Lam, S. P., Yu, M. W. M., Tang, X., & Wing, Y.‐K. (2015). Altered sleep stage transitions of REM sleep: A novel and stable biomarker of narcolepsy. Journal of Clinical Sleep Medicine, 11(8), 885–894. https://doi.org/10.5664/jcsm.4940
Lividini, A., Pizza, F., Filardi, M., Vandi, S., Ingravallo, F., Antelmi, E., Bruni, O., Cosentino, F. I. I., Ferri, R., Guarnieri, B., Marelli, S., Ferini‐Strambi, L., Romigi, A., Bonanni, E., Maestri, M., Terzaghi, M., Manni, R., & Plazzi, G. (2021). Narcolepsy type 1 features across the life span: Age impact on clinical and polysomnographic phenotype. Journal of Clinical Sleep Medicine, 17(7), 1363–1370. https://doi.org/10.5664/jcsm.9198
Lopez, R., Barateau, L., Laura Rassu, A., Evangelista, E., Chenini, S., Scholz, S., Jaussent, I., & Dauvilliers, Y. (2023). Rapid eye movement sleep duration during the multiple sleep latency test to diagnose hypocretin‐deficient narcolepsy. Sleep, 46(1), zsac247. https://doi.org/10.1093/sleep/zsac247
Lopez, R., Doukkali, A., Barateau, L., Evangelista, E., Chenini, S., Jaussent, I., & Dauvilliers, Y. (2017). Test‐retest reliability of the multiple sleep latency test in central disorders of hypersomnolence. Sleep, 40(12), zsx164. https://doi.org/10.1093/sleep/zsx164
Luca, G., Haba‐Rubio, J., Dauvilliers, Y., Lammers, G. J., Overeem, S., Donjacour, C. E., Mayer, G., Javidi, S., Iranzo, A., Santamaria, J., Peraita‐Adrados, R., Hor, H., Kutalik, Z., Plazzi, G., Poli, F., Pizza, F., Arnulf, I., Lecendreux, M., Bassetti, C., … Riha, R. (2013). Clinical, polysomnographic and genome‐wide association analyses of narcolepsy with cataplexy: A European Narcolepsy Network study. Journal of Sleep Research, 22(5), 482–495. https://doi.org/10.1111/JSR.12044
Luppi, P. H., Clement, O., Sapin, E., Peyron, C., Gervasoni, D., Léger, L., & Fort, P. (2012). Brainstem mechanisms of paradoxical (REM) sleep generation. Pflugers Archiv: European Journal of Physiology, 463(1), 43–52. https://doi.org/10.1007/S00424-011-1054-Y
Mahoney, C. E. (2019). The neurobiological basis of narcolepsy. Nature Reviews Neuroscience, 20, 83. https://doi.org/10.1038/s41583-018-0097-x
Mahoney, C. E., Agostinelli, L. J., Brooks, J. N. K., Lowell, B. B., & Scammell, T. E. (2017). GABAergic neurons of the central amygdala promote cataplexy. The Journal of Neuroscience, 37(15), 3995–4006. https://doi.org/10.1523/JNEUROSCI.4065-15.2017
Mamelak, M., Black, J., Montplaisir, J., & Ristanovic, R. (2004). A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep, 27(7), 1327–1334. https://doi.org/10.1093/sleep/27.7.1327
Mamelak, M., Scharf, M. B., & Woods, M. (1986). Treatment of narcolepsy with gamma‐hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep, 9(1 Pt 2), 285–289. https://doi.org/10.1093/sleep/9.1.285
Maski, K., Mignot, E., Plazzi, G., & Dauvilliers, Y. (2022). Disrupted nighttime sleep and sleep instability in narcolepsy. Journal of Clinical Sleep Medicine, 18(1), 289–304. https://doi.org/10.5664/JCSM.9638
Maski, K., Pizza, F., Liu, S., Steinhart, E., Little, E., Colclasure, A., Behn, C. D., Vandi, S., Antelmi, E., Weller, E., Scammell, T. E., & Plazzi, G. (2020). Defining disrupted nighttime sleep and assessing its diagnostic utility for pediatric narcolepsy type 1. Sleep, 43(10), zsaa066. https://doi.org/10.1093/sleep/zsaa066
Maski, K., Trotti, L. M., Kotagal, S., Auger, R. R., Rowley, J. A., Hashmi, S. D., & Watson, N. F. (2021). Treatment of central disorders of hypersomnolence: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(9), 1881–1893. https://doi.org/10.5664/JCSM.9328
Maski, K. P., Colclasure, A., Little, E., Steinhart, E., Scammell, T. E., Navidi, W., & Diniz Behn, C. (2021). Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence. Sleep, 44(7), zsab021. https://doi.org/10.1093/sleep/zsab021
Mayer, G., Rodenbeck, A., & Kesper, K. (2017). Sodium oxybate treatment in narcolepsy and its effect on muscle tone. Sleep Medicine, 35, 1–6. https://doi.org/10.1016/J.SLEEP.2017.03.023
Meletti, S., Vaudano, A. E., Pizza, F., Ruggieri, A., Vandi, S., Teggi, A., Franceschini, C., Benuzzi, F., Nichelli, P. F., & Plazzi, G. (2015). The brain correlates of laugh and cataplexy in childhood narcolepsy. The Journal of Neuroscience, 35(33), 11583–11594. https://doi.org/10.1523/JNEUROSCI.0840-15.2015
Mignot, E., Lammers, G. J., Ripley, B., Okun, M., Nevsimalova, S., Overeem, S., Vankova, J., Black, J., Harsh, J., Bassetti, C., Schrader, H., & Nishino, S. (2002). The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Archives of Neurology, 59(10), 1553–1562. https://doi.org/10.1001/ARCHNEUR.59.10.1553
Mignot, E., Lin, L., Finn, L., Lopes, C., Pluff, K., Sundstrom, M. L., & Young, T. (2006). Correlates of sleep‐onset REM periods during the Multiple Sleep Latency Test in community adults. Brain: A Journal of Neurology, 129(Pt 6), 1609–1623. https://doi.org/10.1093/BRAIN/AWL079
Mitler, M. M., Boysen, B. G., Campbell, L., & Dement, W. C. (1974). Narcolepsy‐cataplexy in a female dog. Experimental Neurology, 45(2), 332–340. https://doi.org/10.1016/0014-4886(74)90122-8
Mitler, M. M., Hajdukovic, R., & Erman, M. K. (1993). Treatment of narcolepsy with methamphetamine. Sleep, 16(4), 306–317.
Mitler, M. M., Van den Hoed, J., Carskadon, M. A., Richardson, G., Park, R., Guilleminault, C., & Dement, W. C. (1979). REM sleep episodes during the Multple Sleep Latency Test in narcoleptic patients. Electroencephalography and Clinical Neurophysiology, 46(4), 479–481. https://doi.org/10.1016/0013-4694(79)90149-4
Mochizuki, T., Crocker, A., McCormack, S., Yanagisawa, M., Sakurai, T., & Scammell, T. E. (2004). Behavioral state instability in orexin knock‐out mice. The Journal of Neuroscience, 24(28), 6291–6300. https://doi.org/10.1523/JNEUROSCI.0586-04.2004
Moghadam, K. K., Pizza, F., La Morgia, C., Franceschini, C., Tonon, C., Lodi, R., Barboni, P., Seri, M., Ferrari, S., Liguori, R., Donadio, V., Parchi, P., Cornelio, F., Inzitari, D., Mignarri, A., Capocchi, G., Dotti, M. T., Winkelmann, J., Lin, L., … Plazzi, G. (2014). Narcolepsy is a common phenotype in HSAN IE and ADCA‐DN. Brain, 137(6), 1643–1655. https://doi.org/10.1093/brain/awu069
Møller, L. R., & Østergaard, J. R. (2009). Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations. Journal of Child and Adolescent Psychopharmacology, 19(2), 197–201. https://doi.org/10.1089/CAP.2008.036
Murer, T., Imbach, L. L., Hackius, M., Taddei, R. N., Werth, E., Poryazova, R., Gavrilov, Y. V., Winkler, S., Waldvogel, D., Baumann, C. R., & Valko, P. O. (2017). Optimizing MSLT specificity in narcolepsy with cataplexy. Sleep, 40(12), zsx173. https://doi.org/10.1093/sleep/zsx173
Nishino, S., & Kanbayashi, T. (2005). Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Medicine Reviews, 9(4), 269–310. https://doi.org/10.1016/J.SMRV.2005.03.004
Nishino, S., Ripley, B., Overeem, S., Lammers, G. J., & Mignot, E. (2000). Hypocretin (orexin) deficiency in human narcolepsy. Lancet, 355(9197), 39–40. https://doi.org/10.1016/S0140-6736(99)05582-8
Ohayon, M. M. (2013). Narcolepsy is complicated by high medical and psychiatric comorbidities: A comparison with the general population. Sleep Medicine, 14(6), 488–492. https://doi.org/10.1016/j.sleep.2013.03.002
Oishi, Y., Williams, R. H., Agostinelli, L., Arrigoni, E., Fuller, P. M., Mochizuki, T., Saper, C. B., & Scammell, T. E. (2013). Role of the medial prefrontal cortex in cataplexy. The Journal of Neuroscience, 33(23), 9743–9751. https://doi.org/10.1523/JNEUROSCI.0499-13.2013
Ollila, H. M., Sharon, E., Lin, L., Sinnott‐Armstrong, N., Ambati, A., Yogeshwar, S. M., Hillary, R. P., Jolanki, O., Faraco, J., Einen, M., Luo, G., Zhang, J., Han, F., Yan, H., Dong, X. S., Li, J., Zhang, J., Hong, S. C., Kim, T. W., … Mignot, E. J. (2023). Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy. Nature Communications, 14(1), 2709. https://doi.org/10.1038/s41467-023-36120-z
Olsen, A. V., Stephansen, J., Leary, E., Peppard, P. E., Sheungshul, H., Jennum, P. J., Sorensen, H., & Mignot, E. (2017). Diagnostic value of sleep stage dissociation as visualized on a 2‐dimensional sleep state space in human narcolepsy. Journal of Neuroscience Methods, 282, 9–19. https://doi.org/10.1016/j.jneumeth.2017.02.004
Parkes, J. D., & Fenton, G. W. (1973). Levo(−) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy. Journal of Neurology, Neurosurgery, and Psychiatry, 36(6), 1076–1081. https://doi.org/10.1136/jnnp.36.6.1076
Partinen, M., Kornum, B. R., Plazzi, G., Jennum, P., Julkunen, I., & Vaarala, O. (2014). Narcolepsy as an autoimmune disease: The role of H1N1 infection and vaccination. The Lancet Neurology, 13(6), 600–613. https://doi.org/10.1016/S1474-4422(14)70075-4
Passouant, P., Schwab, R. S., & Cadilhac, J. (1964). Narcolepsie‐cataplexie: étude du sommeil de nuit et du sommeil de jour: traitement par une amphétamine lévogyre. Revue Neurologique, 111, 415–426.
Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., Li, R., Hungs, M., Pedrazzoli, M., Padigaru, M., Kucherlapati, M., Jun, F., Maki, R., Lammers, G. J., Bouras, C., … Mignot, E. (2000). A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature Medicine, 6(9), 991–997. https://doi.org/10.1038/79690
Pisko, J., Pastorek, L., Buskova, J., Sonka, K., & Nevsimalova, S. (2014). Nightmares in narcolepsy: Underinvestigated symptom? Sleep Medicine, 15(8), 967–972. https://doi.org/10.1016/J.SLEEP.2014.03.006
Pizza, F., Antelmi, E., Vandi, S., Meletti, S., Erro, R., Baumann, C. R., Bhatia, K. P., Dauvilliers, Y., Edwards, M. J., Iranzo, A., Overeem, S., Tinazzi, M., Liguori, R., & Plazzi, G. (2018). The distinguishing motor features of cataplexy: A study from video‐recorded attacks. Sleep, 41(5), 1–9. https://doi.org/10.1093/sleep/zsy026
Pizza, F., Barateau, L., Jaussent, I., Vandi, S., Antelmi, E., Mignot, E., Dauvilliers, Y., & Plazzi, G. (2019). Validation of multiple sleep latency test for the diagnosis of pediatric narcolepsy type 1. Neurology, 93(11), e1034–e1044. https://doi.org/10.1212/WNL.0000000000008094
Pizza, F., Ferri, R., Vandi, S., Rundo, F., Iloti, M., Neccia, G., & Plazzi, G. (2017). Spectral electroencephalography profile of rapid eye movement sleep at sleep onset in narcolepsy type 1. European Journal of Neurology, 24(2), 334–340. https://doi.org/10.1111/ene.13204
Pizza, F., Moghadam, K. K., Vandi, S., Detto, S., Poli, F., Mignot, E., Ferri, R., & Plazzi, G. (2013). Daytime continuous polysomnography predicts MSLT results in hypersomnias of central origin. Journal of Sleep Research, 22(1), 32–40. https://doi.org/10.1111/j.1365-2869.2012.01032.x
Pizza, F., Tartarotti, S., Poryazova, R., Baumann, C. R., & Bassetti, C. L. (2013). Sleep‐disordered breathing and periodic limb movements in narcolepsy with cataplexy: A systematic analysis of 35 consecutive patients. European Neurology, 70(1–2), 22–26. https://doi.org/10.1159/000348719
Pizza, F., Vandi, S., Detto, S., Poli, F., Franceschini, C., Montagna, P., & Plazzi, G. (2011). Different sleep onset criteria at the multiple sleep latency test (MSLT): An additional marker to differentiate central nervous system (CNS) hypersomnias. Journal of Sleep Research, 20(1 Pt 2), 250–256. https://doi.org/10.1111/J.1365-2869.2009.00808.X
Pizza, F., Vandi, S., Iloti, M., Franceschini, C., Liguori, R., Mignot, E., & Plazzi, G. (2015). Nocturnal sleep dynamics identify narcolepsy type 1. Sleep, 38(8), 1277–1284B. https://doi.org/10.5665/SLEEP.4908
Pizza, F., Vignatelli, L., Vandi, S., Zenesini, C., Biscarini, F., Franceschini, C., Antelmi, E., Ingravallo, F., Mignot, E., Bruni, O., Nobili, L., Veggiotti, P., Ferri, R., & Plazzi, G. (2024). Role of daytime continuous polysomnography in the diagnosis of pediatric narcolepsy type 1. Neurology, 102(1), e207815. https://doi.org/10.1212/WNL.0000000000207815
Plazzi, G., Clawges, H. M., & Owens, J. A. (2018). Clinical characteristics and burden of illness in pediatric patients with narcolepsy. Pediatric Neurology, 85, 21–32. https://doi.org/10.1016/j.pediatrneurol.2018.06.008
Plazzi, G., Fabbri, C., Pizza, F., & Serretti, A. (2015). Schizophrenia‐like symptoms in narcolepsy type 1: Shared and distinctive clinical characteristics. Neuropsychobiology, 71(4), 218–224. https://doi.org/10.1159/000432400
Plazzi, G., Ferri, R., Antelmi, E., Bayard, S., Franceschini, C., Cosentino, F. I. I., Abril, B., Spruyt, K., Provini, F., Montagna, P., & Dauvilliers, Y. (2010). Restless legs syndrome is frequent in narcolepsy with cataplexy patients. Sleep, 33(5), 689–694. https://doi.org/10.1093/SLEEP/33.5.689
Plazzi, G., Parmeggiani, A., Mignot, E., Lin, L., Scano, M. C., Posar, A., Bernardi, F., Lodi, R., Tonon, C., Barbiroli, B., Montagna, P., & Cicognani, A. (2006). Narcolepsy‐cataplexy associated with precocious puberty. Neurology, 66(10), 1577–1579. https://doi.org/10.1212/01.WNL.0000216142.21375.71
Plazzi, G., Pizza, F., Palaia, V., Franceschini, C., Poli, F., Moghadam, K. K., Cortelli, P., Nobili, L., Bruni, O., Dauvilliers, Y., Lin, L., Edwards, M. J., Mignot, E., & Bhatia, K. P. (2011). Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain, 134(12), 3477–3489. https://doi.org/10.1093/brain/awr244
Poli, F., Pizza, F., Mignot, E., Ferri, R., Pagotto, U., Taheri, S., Finotti, E., Bernardi, F., Pirazzoli, P., Cicognani, A., Balsamo, A., Nobili, L., Bruni, O., & Plazzi, G. (2013). High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep, 36(2), 175–181. https://doi.org/10.5665/sleep.2366
Poli, F., Plazzi, G., Di Dalmazi, G., Ribichini, D., Vicennati, V., Pizza, F., Mignot, E., Montagna, P., Pasquali, R., & Pagotto, U. (2009). Body mass index‐independent metabolic alterations in narcolepsy with cataplexy. Sleep, 32(11), 1491–1497. https://doi.org/10.1093/SLEEP/32.11.1491
Ponziani, V., Gennari, M., Pizza, F., Balsamo, A., Bernardi, F., & Plazzi, G. (2016). Growing up with type 1 narcolepsy: Its anthropometric and endocrine features. Journal of Clinical Sleep Medicine, 12(12), 1649–1657. https://doi.org/10.5664/jcsm.6352
Postiglione, E., Barateau, L., Pizza, F., Lopez, R., Antelmi, E., Rassu, A. L., Vandi, S., Chenini, S., Mignot, E., Dauvilliers, Y., & Plazzi, G. (2022). Narcolepsy with intermediate cerebrospinal level of hypocretin‐1. Sleep, 45(2), zsab285. https://doi.org/10.1093/sleep/zsab285
Rechtschaffen, A., Wolpert, E. A., Dament, W. C., Mitchell, S. A., & Fisher, C. (1963). Nocturnal sleep of narcoleptics. Electroencephalography and Clinical Neurophysiology, 15(4), 599–609. https://doi.org/10.1016/0013-4694(63)90032-4
Reiter, J., Katz, E., Scammell, T. E., & Maski, K. (2015). Usefulness of a nocturnal SOREMP for diagnosing narcolepsy with cataplexy in a pediatric population. Sleep, 38(6), 859–865. https://doi.org/10.5665/sleep.4728
Richardson, G. S., Carskadon, M. A., Flagg, W., Van den Hoed, J., Dement, W. C., & Mitler, M. M. (1978). Excessive daytime sleepiness in man: Multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalography and Clinical Neurophysiology, 45(5), 621–627. https://doi.org/10.1016/0013-4694(78)90162-1
Ripley, B., Fujiki, N., Okura, M., Mignot, E., & Nishino, S. (2001). Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiology of Disease, 8(3), 525–534. https://doi.org/10.1006/NBDI.2001.0389
Rocca, F. L., Finotti, E., Pizza, F., Ingravallo, F., Gatta, M., Bruni, O., & Plazzi, G. (2016). Psychosocial profile and quality of life in children with type 1 narcolepsy: A case‐control study. Sleep, 39(7), 1389–1398. https://doi.org/10.5665/SLEEP.5970
Roman, A., Meftah, S., Arthaud, S., Luppi, P. H., & Peyron, C. (2018). The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep. Sleep, 41(6), zsy046. https://doi.org/10.1093/SLEEP/ZSY046
Roth, T., Dauvilliers, Y., Bogan, R. K., Plazzi, G., & Black, J. (2024). Effects of oxybate dose and regimen on disrupted nighttime sleep and sleep architecture. Sleep Medicine, 114, 255–265. https://doi.org/10.1016/J.SLEEP.2023.12.015
Roth, T., Dauvilliers, Y., Guinta, D., Alvarez‐Horine, S., Dynin, E., & Black, J. (2017). Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy. Journal of Sleep Research, 26(4), 407–414. https://doi.org/10.1111/JSR.12468
Roth, T., Dauvilliers, Y., Thorpy, M. J., Kushida, C., Corser, B. C., Bogan, R., Rosenberg, R., Dubow, J., & Seiden, D. (2022). Effect of FT218, a once‐nightly sodium oxybate formulation, on disrupted nighttime sleep in patients with narcolepsy: Results from the randomized phase III REST‐ON trial. CNS Drugs, 36(4), 377–387. https://doi.org/10.1007/S40263-022-00904-6
Rubboli, G., D'Orsi, G., Zaniboni, A., Gardella, E., Zamagni, M., Rizzi, R., Meletti, S., Valzania, F., Tropeani, A., & Tassinari, C. A. (2000). A video‐polygraphic analysis of the cataplectic attack. Clinical Neurophysiology, 111(Suppl 2), S120‐8. https://doi.org/10.1016/S1388-2457(00)00412-0
Ruoff, C., Pizza, F., Trotti, L. M., Sonka, K., Vandi, S., Cheung, J., Pinto, S., Einen, M., Simakajornboon, N., Han, F., Peppard, P., Nevsimalova, S., Plazzi, G., Rye, D., & Mignot, E. (2018). The MSLT is repeatable in narcolepsy type 1 but not narcolepsy type 2: A retrospective patient study. Journal of Clinical Sleep Medicine, 14(1), 65–74. https://doi.org/10.5664/jcsm.6882
Saitoh, T., & Sakurai, T. (2023). The present and future of synthetic orexin receptor agonists. Peptides, 167, 171051. https://doi.org/10.1016/J.PEPTIDES.2023.171051
Sansa, G., Falup‐Pecurariu, C., Salamero, M., Iranzo, A., & Santamaria, J. (2014). Non‐random temporal distribution of sleep onset REM periods in the MSLT in narcolepsy. Journal of the Neurological Sciences, 341(1–2), 136–138. https://doi.org/10.1016/j.jns.2014.03.039
Sansa, G., Iranzo, A., & Santamaria, J. (2010). Obstructive sleep apnea in narcolepsy. Sleep Medicine, 11(1), 93–95. https://doi.org/10.1016/J.SLEEP.2009.02.009
Schenck, C. H., & Mahowald, M. W. (1992). Motor dyscontrol in narcolepsy: Rapid‐eye‐movement (REM) sleep without atonia and REM sleep behavior disorder. Annals of Neurology, 32(1), 3–10. https://doi.org/10.1002/ANA.410320103
Schoch, S. F., Werth, E., Poryazova, R., Scammell, T. E., Baumann, C. R., & Imbach, L. L. (2017). Dysregulation of sleep behavioral states in narcolepsy. Sleep, 40(12), zsx170. https://doi.org/10.1093/sleep/zsx170
Seifinejad, A., Li, S., Possovre, M. L., Vassalli, A., & Tafti, M. (2020). Hypocretinergic interactions with the serotonergic system regulate REM sleep and cataplexy. Nature Communications, 11(1), 6034. https://doi.org/10.1038/S41467-020-19862-Y
Silber, M. H., Krahn, L. E., Olson, E. J., & Pankratz, V. S. (2002). The epidemiology of narcolepsy in Olmsted County, Minnesota: A population‐based study. Sleep, 25(2), 197–202. https://doi.org/10.1093/SLEEP/25.2.197
Silvani, A., Vandi, S., Pizza, F., Antelmi, E., Ferri, R., & Plazzi, G. (2021). Combining information on nocturnal rapid eye movement sleep latency and atonia to facilitate diagnosis of pediatric narcolepsy type 1. Sleep, 44(3), zsaa203. https://doi.org/10.1093/sleep/zsaa203
Simoncini Malucelli, G., Mercante, A., Pizza, F., Brunetti, V., Biscarini, F., Vandi, S., Mazzoni, A., Franceschini, C., Della Marca, G., Vollono, C., Chieffo, D. P. R., & Plazzi, G. (2023). Exploring the emotional and behavioural profile in paediatric narcolepsy type 1: A case‐control study. Journal of Sleep Research, e14064. Epub ahead of print. https://doi.org/10.1111/JSR.14064
Sorensen, G. L., Knudsen, S., & Jennum, P. (2013). Sleep transitions in hypocretin‐deficient narcolepsy. Sleep, 36(8), 1173–1177. https://doi.org/10.5665/SLEEP.2880
Stephansen, J. B., Olesen, A. N., Olsen, M., Ambati, A., Leary, E. B., Moore, H. E., Carrillo, O., Lin, L., Han, F., Yan, H., Sun, Y. L., Dauvilliers, Y., Scholz, S., Barateau, L., Hogl, B., Stefani, A., Hong, S. C., Kim, T. W., Pizza, F., … Mignot, E. (2018). Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy. Nature Communications, 9(1), 5229. https://doi.org/10.1038/S41467-018-07229-3
Sun, Y., Ranjan, A., Tisdale, R., Ma, S.‐C., Park, S., Haire, M., Heu, J., Morairty, S. R., Wang, X., Rosenbaum, D. M., Williams, N. S., De Brabander, J. K., & Kilduff, T. S. (2023). Evaluation of the efficacy of the hypocretin/orexin receptor agonists TAK‐925 and ARN‐776 in narcoleptic orexin/tTA; TetO‐DTA mice. Journal of Sleep Research, 32(4), e13839. https://doi.org/10.1111/jsr.13839
Szakács, A., Chaplin, J. E., Tideman, P., Strömberg, U., Nilsson, J., Darin, N., & Hallböök, T. (2019). A population‐based and case‐controlled study of children and adolescents with narcolepsy: Health‐related quality of life, adaptive behavior and parental stress. European Journal of Paediatric Neurology, 23(2), 288–295. https://doi.org/10.1016/j.ejpn.2019.01.004
Szakacs, Z., Dauvilliers, Y., Mikhaylov, V., Poverennova, I., Krylov, S., Jankovic, S., Sonka, K., Lehert, P., Lecomte, I., Lecomte, J. M., & Schwartz, J. C. (2017). Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: A randomised, double‐blind, placebo‐controlled trial. The Lancet. Neurology, 16(3), 200–207. https://doi.org/10.1016/S1474-4422(16)30333-7
Tafti, M., Villemin, E., Carlander, B., Besset, A., & Billiard, M. (1992). Sleep onset rapid‐eye‐movement episodes in narcolepsy: REM sleep pressure or nonREM‐REM sleep dysregulation? Journal of Sleep Research, 1(4), 245–250. https://doi.org/10.1111/J.1365-2869.1992.TB00046.X
Terzaghi, M., Ratti, P. L., Manni, F., & Manni, R. (2012). Sleep paralysis in narcolepsy: More than just a motor dissociative phenomenon? Neurological Sciences, 33(1), 169–172. https://doi.org/10.1007/S10072-011-0644-Y
Terzano, M. G., Smerieri, A., Del Felice, A., Giglia, F., Palomba, V., & Parrino, L. (2006). Cyclic alternating pattern (CAP) alterations in narcolepsy. Sleep Medicine, 7(8), 619–626. https://doi.org/10.1016/J.SLEEP.2005.12.003
Thannickal, T. C., Moore, R. Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., & Siegel, J. M. (2000). Reduced number of hypocretin neurons in human narcolepsy. Neuron, 27(3), 469–474. https://doi.org/10.1016/S0896-6273(00)00058-1
Thannickal, T. C., Nienhuis, R., & Siegel, J. M. (2009). Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep, 32(8), 993–998. https://doi.org/10.1093/SLEEP/32.8.993
Trotti, L. M., Staab, B. A., & Rye, D. B. (2013). Test‐retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and idiopathic hypersomnia. Journal of Clinical Sleep Medicine, 9(8), 789–795. https://doi.org/10.5664/jcsm.2922
Um, Y. H., Oh, J., Kim, S.‐M., Kim, T.‐W., Seo, H.‐J., Jeong, J.‐H., & Hong, S.‐C. (2022). Differential characteristics of repeated polysomnography and multiple sleep latency test parameters in narcolepsy type 1 and type 2 patients: A longitudinal retrospective study. Sleep & Breathing = Schlaf & Atmung, 26(4), 1939–1946. https://doi.org/10.1007/s11325-021-02525-7
Van Der Hoeven, A. E., Fronczek, R., Schinkelshoek, M. S., Roelandse, F. W. C., Bakker, J. A., Overeem, S., Bijlenga, D., & Lammers, G. J. (2022). Intermediate hypocretin‐1 cerebrospinal fluid levels and typical cataplexy: Their significance in the diagnosis of narcolepsy type 1. Sleep, 45(5), zsac052. https://doi.org/10.1093/sleep/zsac052
Vandi, S., Pizza, F., Antelmi, E., Neccia, G., Iloti, M., Mazzoni, A., Avoni, P., & Plazzi, G. (2019). A standardized test to document cataplexy. Sleep Medicine, 53, 197–204. https://doi.org/10.1016/J.SLEEP.2017.08.021
Vandi, S., Rodolfi, S., Pizza, F., Moresco, M., Antelmi, E., Ferri, R., Mignot, E., Plazzi, G., & Silvani, A. (2019). Cardiovascular autonomic dysfunction, altered sleep architecture, and muscle overactivity during nocturnal sleep in pediatric patients with narcolepsy type 1. Sleep, 42(12), zsz16. https://doi.org/10.1093/SLEEP/ZSZ169
Vassalli, A., Dellepiane, J. M., Emmenegger, Y., Jimenez, S., Vandi, S., Plazzi, G., Franken, P., & Tafti, M. (2013). Electroencephalogram paroxysmal θ characterizes cataplexy in mice and children. Brain: A Journal of Neurology, 136(Pt 5), 1592–1608. https://doi.org/10.1093/BRAIN/AWT069
Vaudano, A. E., Pizza, F., Talami, F., Plazzi, G., & Meletti, S. (2019). The neuronal network of laughing in young patients with untreated narcolepsy. Neurology, 92(5), E504–E515. https://doi.org/10.1212/WNL.0000000000006853
Vetrugno, R., D'Angelo, R., Moghadam, K. K., Vandi, S., Franceschini, C., Mignot, E., Montagna, P., & Plazzi, G. (2010). Behavioural and neurophysiological correlates of human cataplexy: A video‐polygraphic study. Clinical Neurophysiology, 121(2), 153–162. https://doi.org/10.1016/J.CLINPH.2009.10.012
Vignatelli, L., Plazzi, G., Peschechera, F., Delaj, L., & D'Alessandro, R. (2011). A 5‐year prospective cohort study on health‐related quality of life in patients with narcolepsy. Sleep Medicine, 12(1), 19–23. https://doi.org/10.1016/j.sleep.2010.07.008
Vilela, M., Tracey, B., Volfson, D., Barateau, L., Cai, A., Buhl, D. L., & Dauvilliers, Y. (2024). Identifying time‐resolved features of nocturnal sleep characteristics of narcolepsy using machine learning. Journal of Sleep Research, e14216. Epub ahead of print. https://doi.org/10.1111/JSR.14216
Vogel, G. (1960). Studies in psychophysiology of dreams. Archives of General Psychiatry, 3(4), 421. https://doi.org/10.1001/archpsyc.1960.01710040091011
Wang, J., & Greenberg, H. (2013). Status cataplecticus precipitated by abrupt withdrawal of venlafaxine. Journal of Clinical Sleep Medicine, 9(7), 715–716. https://doi.org/10.5664/JCSM.2848
Westphal, C. (1877). Eigetumliche mit Einschlafen verbundene Anfalle. Archives of Psychiatry. https://cir.nii.ac.jp/crid/1572543025076757888, 7, 631–635.
Wichniak, A., Wierzbicka, A., Walęcka, M., & Jernajczyk, W. (2017). Effects of antidepressants on sleep. Current Psychiatry Reports, 19(9), 1–7. https://doi.org/10.1007/s11920-017-0816-4
Wilson, R., Raynal, D., Guilleminault, C., Zarcone, V., & Dement, W. (1973). REM sleep latencies in daytime sleep recordings of narcoleptics. Sleep Research, 2, 166.
Xu, X. M., Wei, Y. D., Liu, Y., & Li, Z. X. (2019). Gamma‐hydroxybutyrate (GHB) for narcolepsy in adults: An updated systematic review and meta‐analysis. Sleep Medicine, 64, 62–70. https://doi.org/10.1016/J.SLEEP.2019.06.017
Yon, M. I., Azman, F., Yon, M. E., & Tezer, F. I. (2021). Nocturnal rapid eye movement sleep without atonia can be a diagnostic parameter in differentiating narcolepsy type 1 from type 2. Journal of Clinical Neurophysiology, 38(3), 237–241. https://doi.org/10.1097/WNP.0000000000000688
Yoss, R., & Daly, D. (1957). Criteria for the diagnosis of the narcoleptic syndrome. Proceedings of the staff meetings. Mayo Clinic, 32(12), 320–328.
Yoss, R. E., & Daly, D. (1959). Treatment of narcolepsy with ritalin. Neurology, 9(3), 171–173. https://doi.org/10.1212/WNL.9.3.171
Yukitake, H., Fujimoto, T., Ishikawa, T., Suzuki, A., Shimizu, Y., Rikimaru, K., Ito, M., Suzuki, M., & Kimura, H. (2019). TAK‐925, an orexin 2 receptor‐selective agonist, shows robust wake‐promoting effects in mice. Pharmacology, Biochemistry, and Behavior, 187, 172794. https://doi.org/10.1016/j.pbb.2019.172794
Zeitzer, J. M., Nishino, S., & Mignot, E. (2006). The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions. Trends in Pharmacological Sciences, 27(7), 368–374. https://doi.org/10.1016/J.TIPS.2006.05.006
Zhang, Z., Mayer, G., Dauvilliers, Y., Plazzi, G., Pizza, F., Fronczek, R., Santamaria, J., Partinen, M., Overeem, S., Peraita‐Adrados, R., Da Silva, A. M., Sonka, K., Del Rio‐Villegas, R., Heinzer, R., Wierzbicka, A., Young, P., Högl, B., Bassetti, C. L., Manconi, M., … Khatami, R. (2018). Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning. Scientific Reports, 8(1), 10628. https://doi.org/10.1038/s41598-018-28840-w